STOCK TITAN

Brunswick Corp (NYSE: BC) director gets 562-share stock grant

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Brunswick Corp director Joseph W. McClanathan received a grant of 562 shares of common stock on July 31, 2026 at a reference price of $79.00 per share. After this award, he beneficially owns 28,238 shares, including 114 shares acquired through dividend reinvestment through June 2026.

Positive

  • None.

Negative

  • None.
Insider MCCLANATHAN JOSEPH W
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 562 $79.00 $44K
Holdings After Transaction: Common Stock — 28,238 shares (Direct)
Footnotes (1)
  1. F1. Beneficial holdings include 114 shares acquired pursuant to dividend reinvestment through June 2026.
Shares granted 562 shares Common Stock award to director on July 31, 2026
Grant reference price $79.00 per share Per-share value associated with the 562-share stock grant
Shares owned after transaction 28,238 shares Director’s beneficial holdings following the July 31, 2026 award
Dividend reinvestment shares 114 shares Portion of beneficial holdings acquired via dividend reinvestment through June 2026
beneficial holdings financial
"Beneficial holdings include 114 shares acquired pursuant to dividend reinvestment"
dividend reinvestment financial
"114 shares acquired pursuant to dividend reinvestment through June 2026"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
grant, award, or other acquisition financial
"Transaction code A is described as a grant, award, or other acquisition"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Brunswick Corp (BC) report for Joseph W. McClanathan?

Brunswick Corp (BC) reported that director Joseph W. McClanathan received a grant of 562 shares of common stock on July 31, 2026. The transaction is coded as a grant, award, or other acquisition, not an open-market purchase or sale.

How many Brunswick Corp (BC) shares does Joseph W. McClanathan own after this transaction?

Following the July 31, 2026 stock grant, Joseph W. McClanathan beneficially owns 28,238 shares of Brunswick Corp (BC) common stock. This total includes 114 shares that were acquired separately through dividend reinvestment through June 2026.

What was the reference price for the Brunswick Corp (BC) stock grant to McClanathan?

The 562-share stock grant to Joseph W. McClanathan used a reference price of $79.00 per share. This price is reported as a per-share value associated with the award, rather than indicating an open-market purchase or sale transaction.

Was Joseph W. McClanathan’s Brunswick Corp (BC) transaction made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not selected, meaning the reported grant of 562 shares was not executed under an affirmed Rule 10b5-1 trading plan. It instead reflects a compensation-related stock award.

How many of McClanathan’s Brunswick Corp (BC) shares come from dividend reinvestment?

McClanathan’s beneficial holdings include 114 shares of Brunswick Corp (BC) common stock acquired through dividend reinvestment through June 2026. These dividend-reinvestment shares form part of his total 28,238-share beneficial ownership position after the July 31, 2026 award.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MCCLANATHAN JOSEPH W

(Last)(First)(Middle)
C/O BRUNSWICK CORPORATION
26125 N RIVERWOODS BLVD SUITE 500

(Street)
METTAWA ILLINOIS 60045-3420

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BRUNSWICK CORP [ BC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026A562A$7928,238(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Beneficial holdings include 114 shares acquired pursuant to dividend reinvestment through June 2026.
Remarks:
By: Power of Attorney For: /s/ Joseph W. McClanathan08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)